- Title
- COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
- Creators
- Jeremy M. Shefner - Creighton UniversityAmmar Al-Chalabi - King's College LondonJinsy A. Andrews - The Neurological InstituteAdriano Chio - University of TurinMamede De Carvalho - University of LisbonBettina M. Cockroft - Sangamo BioSciences (United States)Philippe Corcia - Centre Hospitalier Universitaire de ToursPhilippe Couratier - Hôpital DupuytrenMerit E. Cudkowicz - Massachusetts General HospitalAngela Genge - Montreal Neurological Institute and Hospitalet al.
- Publication Details
- Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.24(5-6), pp.523-534
- Number of pages
- 12
- Grant note
- Cytokinetics (http://data.elsevier.com/vocabulary/SciValFunders/100014941)
- Identifiers
- 991006262219802656
- Academic Unit
- Neurology
- Language
- English
- Resource Type
- Journal article
Journal article
COURAGE-ALS: a randomized, double-blind phase 3 study designed to improve participant experience and increase the probability of success
Amyotrophic lateral sclerosis and frontotemporal degeneration, Vol.24(5-6), pp.523-534
07/03/2023
PMID: 37254449
Related links
Metrics
1 Record Views